The pharmaceutical industry in India, known as the “pharmacy of the world,” has recently faced a significant challenge as the U.S. Food and Drug Administration (FDA) cracks down on Indian pharma firms after a two-year hiatus. This crackdown has raised concerns about the quality and safety of drugs manufactured in India, which has been a leading supplier of generic medications worldwide. In this article, we will explore the reasons behind the FDA’s actions, the impact on India’s pharmaceutical industry, the challenges faced by Indian pharma firms, and the steps taken to address the issues.
- Home Web Stories Archive by category "News"
Stay informed about the latest FDA news and announcements from June 2, 2023. Discover important updates on regulations, approvals, and more.
In the past few weeks or months type of flu i.e., “tomato fever” has shown its head up in many regions of India. Due to the shape, color and size of the patches which are generally observed in this flu are similar to tomatoes so healthcare professionals termed this a ‘tomato fever’.